title: Issues in designing a randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome: Comment on Wang et al. Randomized controlled trial of levofloxacin, terazosin, and combination therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome. Int Urol Nephrol. 2016;48:13-18.
authors.affiliation: Department of Surgery, Clinical Hospital Center Zagreb, Kišpatićeva 12, 10000, Zagreb, Croatia. dinopapes@gmail.com.
authors.forename: Dino
authors.initials: D
authors.lastname: Papeš
authors.affiliation: Department of Surgery, Clinical Hospital Center Zagreb, Kišpatićeva 12, 10000, Zagreb, Croatia.
authors.forename: Miram
authors.initials: M
authors.lastname: Pasini
authors.affiliation: Department of Research in Biomedicine and Health, University of Split School of Medicine, Split, Croatia.
authors.forename: Ana
authors.initials: A
authors.lastname: Jerončić
mesh_terms: D006801:Humans; D064704:Levofloxacin; D008297:Male; D017699:Pelvic Pain; D011224:Prazosin / Q000031:analogs & derivatives; D011472:Prostatitis
chemical_list: D064704:Levofloxacin; C041226:Terazosin; D011224:Prazosin